Therefore, one might speculate that our unexpected observation of a 50% reduction in the fatty acid translocase CD36 alongside lipid accumulation in HepG2 cells under hyperglycemia/hyperinsulinemia might be a compensatory mechanism. This evidence concerns the gene CD36 and Hyperglycemia.